Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Cardiology|September 25, 2007
Right aortic arch with mirror image branching and vascular ringYasutomi Higashikuni, Tamon Nagashima, Nobukazu Ishizaka, et al.
Oncology|September 13, 2021
Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative StudyTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective StudyTakeshi Hatanaka, Satoru Kakizaki, Daisuke Uehara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 25, 2019
Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective studyTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Cancers|October 14, 2020
Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression TreatmentTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Biomedicines|May 27, 2023
A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver DiseasesKen Sato, Atsushi Naganuma, Tamon Nagashima, et al.
Internal Medicine (Tokyo, Japan)|October 4, 2021
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed AppropriatelyHiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 22, 2019
Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failureHiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, et al.
Oncology|December 6, 2020
The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World StudyTakeshi Hatanaka, Atsushi Naganuma, Mitsuhiko Shibasaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirinKen Sato, Atsushi Naganuma, Tamon Nagashima, et al.
Pageof 2